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The aim of this study was to characterize the proliferative activity of the anti-histone H1 IgGs towards human T-leukaemia CEM 
cells. Materials and Methods: Anti-histone H1 IgGs were purified from blood serum of systemic lupus erythematosus patients 
by precipitation of serum proteins with 50% ammonium sulfate followed by a sequential affinity chromatography on Protein G-
Sepharose and histone H1-Sepharose columns. To avoid contamination with other proteins, anti-histone H1 IgGs were subjected 
to strongly acidic pH 2.0 during gel filtration through HPLC column. The effects of the anti-histone H1 IgGs on cell viability and 
cell cycle were tested by MTS-assay and flow cytometry, correspondingly. The cross-reactivity of the anti-histone H1 antibodies 
towards heterogenetic and cellular antigens was evaluated by Western-blot analysis. Results: It was found that incubation of CEM 
cells with the HPLC-purified anti-histone H1 IgGs resulted in significant stimulation of cell growth by 46% after 48 h of incuba-
tion. These IgGs possess an antigenic poly-specificity to positively charged heterogenetic antigens and different cellular antigens. 
FITC-labeled and biotinylated anti-histone H1 IgGs are internalized by CEM cells and preferentially accumulated in the cytoplasm. 
Conclusion: The anti-histone H1 IgGs are shown to internalize human T-leukemia CEM and stimulate their proliferation. These 
IgGs are polyspecific toward cellular antigens.
Key Words: autoantibodies, IgGs, systemic lupus erythematosus, blood serum, human T-leukemia CEM cells, cross-reactivity, 
cell proliferation.
Targeting intracellular proteins and nucleic ac-
ids by the components of humoral immune system 
is a principal characteristic of the systemic autoimmune 
diseases. An appearance of the autoantibodies pos-
sessing reactivity with different intracellular antigens 
and associated with systemic autoimmune diseases 
was also found in cancer patients. The anti-nuclear 
auto antibodies play a key role since they were detected 
in ~ 90% of systemic lupus erythematosus (SLE) pa-
tients [1, 2] and ~ 30% of cancer patients [3]. The re-
activity of the autoantibodies with double-stranded DNA 
and histones is a typical and frequently observed im-
munologic abnormality in the SLE patients [4]. The anti-
DNA antibodies (Abs) found in blood serum of these 
patients were studied in detail and were shown to be up-
taken in vitro by a variety of cells, including renal tubular 
cells, lymphocytes, Chinese hamster ovary cells, and 
transformed hamster ﬁbroblasts [5, 6]. Former studies 
of structure, functions, and pathogenicity of the anti-
DNA autoantibodies revealed their dual role — double 
substrate specificity (hydrolysis of DNA and RNA) and 
toxicity towards tumor cell lines [7]. Although the anti-
histone Abs were found in both cancer and rheumatic 
autoimmune patients [8], their effect towards tumor 
cells remains poorly studied. Earlier, we have shown 
that IgGs purified from blood serum of the multiple 
myeloma patients by means of the affinity chromato-
graphy on calf thymus histone H1-Sepharose column 
were capable to stimulate proliferation of T-leukemia 
CEM cells in vitro [9]. The proliferative effect of the anti-
histone H1 Abs isolated from blood serum of the SLE 
patients and human milk towards different lines of tumor 
cells was also demonstrated in vitro [10, 11]. However, 
the mechanisms of such interaction of these IgGs with 
tumor cells, as well as their antigenic characteristics 
remained unknown.
Here we demonstrated that the proliferative anti-
histone H1 IgGs that were purified using affinity chro-
matography from blood serum of the SLE patients 
possess the antigenic poly-specificity to different 
heterogenetic and cellular antigens. These IgGs were 
also internalized by human T-leukemia CEM cells and 
preferentially accumulated in their cytoplasm. Specific 
motives capable of interacting with Mode 1 binding site 
of the 14–3–3 protein and SH3-domain of tyrosine-
protein kinase ITK/TSK were detected in the IgG 1 and 
IgG 3 subclasses by the analysis of Scansite database 
using a Motif Scan program.
MATERIALS AND METHODS
Patients. Blood serum was prepared from the pe-
ripheral blood of the SLE patients diagnosed according 
to American College of Rheumatology criteria for SLE, 
and healthy donors under the approval of the Review 
Board of the Danylo Halytsky Lviv National Medical 
University, in accordance with the regulations of the 
Ministry of Health of Ukraine. A documented consent 
was obtained from all patients included in the study, 
and the form of the informed consent was approved 
by the Bio-Ethics Review Board of the Danylo Halytsky 
Lviv National Medical University.
Cell culture. Human T-leukemia CEM cells were ob-
tained from the Bank of Cell Lines of Human and Animal 
Tissues of the R.E. Kavetsky Institute of Experimental 
Pathology, Oncology and Radiobiology, the National 
Academy of Sciences of Ukraine (Kyiv, Ukraine). Cells 
were maintained in the RPMI-1640 culture medium 
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(Sigma Chemical Co., USA) supplemented with 10% 
fetal bovine serum (Sigma) and gentamycin (50 μg/ml, 
Sigma, USA). Cell cultures were maintained in the atmo-
sphere of 5% CO2, 95% air at 37 °C and 100% humidity.
Purification of anti-histone H1 IgGs. IgGs were 
obtained from blood serum of SLE patients using a se-
quential procedure described elsewhere [12]. Briefly, 
triple precipitation of blood serum proteins with the 
ammonium sulfate was followed with the affinity chro-
matography on Protein-G and histone H1-Sepharose 
columns. The anti-histone H1 IgGs were additionally 
purified by a size exclusion chromatography on Per-
kin Elmer HPLC Series 200 system using Bio-Sil SEC 
250 Column (Bio-Rad, Marnes-la-Coquette, France) 
in 0.1 M Glycine-HCl, pH 2.6 buffer at 1 ml/min ﬂow 
rate, as described in [12]. The protein fractions cor-
responding to the main peak of IgG were collected, 
neutralized with 1.5 M Tris-HCl, pH 8.8, dialyzed for 
18 h against the TBS, and further analysed by the 
gradient (7–16.5%) SDS polyacrylamide gel electro-
phoresis at the non-reducing conditions [13].
Cell viability and proliferation assay. Cells were 
seeded into 96-well plate at a starting concentration 
of 50,000 cells/ml. 20 μg/ml of the Abs in the PBS 
were added to the cultured cells and incubated for 24, 
48 and 72 h. A part of viable cells after Abs treatment 
was determined by the MTT (3-[4,5-dimethylthiazol-
2-yl]-2,5-diphenyltetrazolium bromide; thiazolyl blue) 
assay as recommended by the manufacturer (Sigma, 
USA). 10 μl of MTS/PMS solution (2 mg/ml/0.92 mg/ml, 
1:20) were added to each well followed by 1 h incuba-
tion at 37 °C in humidified (100%) atmosphere with 5% 
CO2. The purple product of the reaction (formazan 
crystals dissolved in the DMSO) was quantitatively 
measured in a multi-channel microphotometer BioTek 
76 883 (BioTek, USA) at 490 nm/630 nm wave length.
Flow cytometry was conducted for cell cycle 
analysis by using BD FACSCalibur machine (Becton 
Dickinson, USA) according to the manufacturer’s in-
structions and generally accepted procedures. CEM 
cells were seeded into 24-well plates at starting 
concentration of 200,000 cells/ml, 20 μg/ml of anti-
histone H1 IgGs were added, and cells were incubated 
for 72 h. Control and IgG-treated cells were collected, 
washed with the PBS, fixed in 70% ice-cold ethanol, 
and stored at 4 °C. For analysis of cell cycle, the cells 
were transferred into the PBS, incubated with RNAse 
A (10 μg/ml) for 30 min at 37 °C, followed by 30 min 
treatment with 50 mg/ml propidium iodide. The inten-
sity of fluorescence was measured by flow cytometry 
at FL2 with FL2A/FL2W cell population gating.
Cross-reactivity study. Western-blot analysis 
was applied for studying anti-histone H1 IgGs cross-
reactivity with various antigens. Total histones from 
calf thymus (10 μg), bovine myelin basic protein (5 μg), 
chicken egg lysozyme, bovine cytochrome C (5 μg), 
bovine milk casein (5 μg) and bovine serum albumin 
(5 μg) were used as targeted antigens. Total cell ly-
sates were obtained by the incubation (30 min on ice) 
of T-leukemia CEM cells with lysis buffer (20 mM Tris-
HCl (pH 7.4), 1% Triton X-100, 150 mM NaCl) con-
taining protease inhibitor mixture. The cell lysate 
was centrifuged at 12,000 g for 15 min at 4 °С, and 
the supernatant was collected. Plasma membrane 
and cytosolic fraction of T-leukemia CEM cells were 
isolated, as described in [14]. Protein concentration 
in the collected fractions was measured using Bio-
Rad Protein Assay Kit (Great Britain), and the aliquots 
containing 30–40 μg of protein were separated by the 
SDS-electrophoresis in 12% polyacrylamide gels [13]. 
The blots were incubated with 20 μg/ml of the anti-
histone H1 IgGs for 18 h at 4 °C and for 1 h with se-
condary anti-human IgG antibody covalently bound 
to a horseradish peroxidase. After incubation, the 
membrane was washed with TBST (20 mM Tris-HCl 
(pH 7.4), 0.05% Tween 20, 150 mM NaCl) and deve-
loped using the ECL kit.
Intracellular accumulation of anti-histone 
H1 IgGs. To study the accumulation of the anti-histone 
H1 IgGs in CEM cells these Abs were pre-labeled 
with FITC. T-leukemia CEM cells were seeded into 
96-well plates and incubated for 2 h in the presence 
of a mixture of FITC-labeled anti-histone H1 IgGs 
(2 μM) at 37 °C in the atmosphere of 5% CO2. After 
such incubation, the cells were observed under dif-
ferential interference contrast using fluorescent Zeiss 
AzioI mager A1 microscope (Carl Zeiss, Germany) 
equipped with excitation BP 470/40 nm filter and emis-
sion BP 525/50 nm filter. Imaging was conducted using 
AxioCam MRm digital camera (Carl Zeiss, Germany).
Intracellular accumulation of IgGs by CEM cells 
was also tested by incubating 10 μg/ml previously 
biotinylated anti-histone H1 IgGs with CEM cells 
for 24 h at standard conditions. The cytochemi-
cal analysis was performed, as described previ-
ously [14]. Briefly, the cells were washed 3 times with 
PBS, fixed with methanol, permeabilized with Triton 
X-100 (0.1%), blocked with 5% BSA and incubated 
with 1 μg/ml of streptavidin-Alexa546, washed, coun-
terstained with DAPI and mounted into a permanent 
slide. Cells were analyzed using Zeiss LSM780 Laser 
Confocal System using a corresponding laser and 
detector wavelength, 63×1.4 NA oil immersion objec-
tive and Zen 2011 software for image processing. Cell 
optical sections with the thickness of 0.4 μm in Z-plane 
were analyzed (usually the whole cell consisted 
of 9 to 11 such sections) for the presence of Alexa 
signal and of nucleic acid detected by DAPI staining. 
The resolution in XY-planes was 0.13 μm.
Penetration of the anti-histone H1 IgGs in T-leuke-
mia CEM cells was also checked using Western-blot 
analysis. 1 000,000 cells/ml were incubated with 
20 μg/ml of the biotinylated Abs for 2 or 24 h at 37 °C. Af-
ter that, the cells were washed three times with the PBS 
followed by centrifugation at 1,500 g, and the cellular 
cytoplasmic fraction was obtained, as described [14]. 
Briefly, the cells were suspended in the hypotonic 
buffer (10 mM Tris-HCl, pH 7.5, 1.5 mM MgCl2, 
1 mM PMSF), and then homogenized in a Potter 
homogenizer on ice followed with centrifugation for 
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10 min at 10,000 g. The supernatant was collected 
and used in Western-blot analysis.
Statistical analysis. Statistical significance of the 
differences between the groups was assessed by Stu-
dent’s t-test.
RESULTS AND DISCUSSION
IgGs possessing an affinity to histone H1 were 
isolated from blood serum of SLE patients using a pro-
cedure described in [9]. Since isolation of anti-histone 
H1 IgGs from blood serum by a sequential affinity 
chromatography does not rule out the pre sence of bio-
logically active contaminants (for example, bacterial 
lipopolysaccharides), we used an additional purifi-
cation step, namely size exclusion chromato graphy 
of IgG preparations at high acidic conditions [12]. 
That allowed a separation of Abs molecules from 
weakly and strongly bound antigens [6, 7, 9]. The 
chromatographic peak at 150 kDa (Fig. 1) containing 
electrophoretically pure IgGs was further examined 
for the proliferation stimulating activity towards human 
leukemia CEM T-cells. To estimate cells viability and 
proliferative activity, MTT assay widely used to measure 
cytotoxicity of the studied agent, has been applied. 
It was found that 48 h incubation of CEM cells with 
anti-histone H1 IgGs resulted in significant increase 
(> 40%, p <0.05) of cell proliferation compared with 
control cells and cells incubated with IgGs collected 
as flow-throw from histone H1-Sepharose column 
named as unbound IgGs (Fig. 2). Besides, proliferation 
stimulating effect of the anti-histone H1 Abs towards 
CEM cells was confirmed by FACS analysis of cell 
cycle. A marked increase in the proportion of cells 
in G2/M stage and a decrease in the amount of G1-cells 
were detected (Fig. 3). Thus, the anti-histone IgGs 
purified from blood serum of SLE patients by two-
step sequential affinity chromatography, are capable 
of stimulating CEM cell proliferation.
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Fig. 1. Effect of highly purified anti-histone H1 Abs on growth 
and survival of CEM cells in vitro. HPLC size exclusion chroma-
tography at pH 2.6 of anti-histone H1 IgGs isolated from blood 
serum of SLE patients by affinity chromatography on histone 
H1-Sepharose column. IgG fraction indicated in the box was 
collected and used for SDS polyacrylamide gel electrophoresis 
(shown in the insert). M — protein molecular markers (Fermen-
tas, Lithuania). The arrow shows the position of IgG molecules
Next, we have studied cross-reactivity of the purified 
anti-histone H1 IgGs towards different artificial antigens 
and potential antigenic proteins of the subfractions 
of CEM cells. The cationic proteins (total histones from 
calf thymus, bovine myelin basic protein, chicken egg 
lysozyme, and bovine cytochrome C), as well as the 
non-cationic proteins (bovine casein and bovine se-
rum albumin) were used as the artificial antigens for 
these IgGs. Total lysate of CEM cells was obtained and 
its crude membrane and cytosolic subfractions were 
isolated by the differential centrifugation of cell lysate 
in order to prepare cell antigens. Purified anti-histone 
H1 IgGs bound the cationic proteins (Fig. 4, a; lanes 
1–3), in contrast to the non-cationic proteins whose 
binding by the IgGs was not detected (Fig. 4, a, lanes 
4–6). In another experiment, we observed an affinity 
of the anti-histone H1 IgGs to a variety of membrane and 
cytoplasmic proteins (Fig. 4, b, lanes 1–3). These data 
demonstrate that affinity of IgGs purified from blood 
serum of the SLE patients using histone H1-Sepharose 
column possess a cross-reactivity to different artificial 
cationic proteins and several cellular antigens.
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Fig. 2. The proliferation of CEM cells treated in vitro with anti-
histone H1 IgGs. Unbound IgGs — the IgG fraction not bound 
with histone H1-Sepharose during column affinity chromatogra-
phy (flow-throw). The statistical analysis for three independent 
experiments is represented. *p < 0.05
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Fig. 3. FACS analysis (measurement of DNA content after 
propidium iodine staining) of cell cycle in the intact (black line) 
and anti-histone H1 IgGs-treated (grey area) CEM leukemia cells
To determine whether the anti-histone H1 IgGs 
could be internalized by human T-leukemia SEM cells, 
the fluorescent and confocal microscopy were used. 
Cells were incubated for 2 h at 37 °C with a fluorescently 
labeled Abs that caused an intensive fluorescence 
found mainly in cell cytoplasm (Fig. 5, a). Confocal 
microscopy of CEM cells treated with the biotiny-
lated anti-histone H1 IgGs confirmed that suggestion 
(Fig. 5, b). An alternative method based on the iden-
tification of IgGs present in rough-purified cytosolic 
Experimental Oncology 39, 36–41, 2017 (March) 39
subfraction of cells was used. CEM cells were incu-
bated for 2 or 24 h with the biotinylated anti-histone 
H1 IgGs, then they were thoroughly washed, lysed, and 
the cytosolic fraction was obtained by centrifugation 
of damaged cells [14]. Western-blot analysis using 
the avidin-HRP conjugates demonstrated a presence 
of the IgGs in the studied cytosolic fraction (Fig. 5, c). 
Thus, these anti-histone H1 IgGs purified from blood 
serum of the SLE patients can be internalized by hu-
man T-leukemia SEM cells and are accumulated pre-
ferentially in the cytoplasm of treated cells.
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Fig. 4. Cross-reactivity of anti-histone H1 IgGs with heteroge-
netic antigens (a): total histones of calf thymus (lane 1), bovine 
myelin basic protein (lane 2), chicken egg lysozyme (lane 3), 
bovine cytochrome C (lane 4), bovine milk casein (lane 5), 
bovine serum albumin (lane 6); and cellular antigens (b): total 
lysate of CEM leukemia cells (lane 1), their cytosolic (lane 2) 
and membrane (lane 3) fractions. As a control, proteins of a total 
cell lysate (lane 1’), cytosolic (lane 2’), and membrane fractions 
(lane 3’) were treated only with Avidin-HRP conjugates
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Fig. 5. Intracellular accumulation of the anti-histone H1 IgG Abs 
in the intact cells in vitro. (a) Results of differential interference 
contrast and fluorescent microscopy of CEM cells after 2 h in-
cubation with FITC-labeled anti-histone H1 IgGs. (b) Confocal 
microscopy of intracellular accumulation of biotin-labeled anti-
histone H1 IgGs in intact CEM cells in vitro after 24 h incubation 
with these IgGs. (c) Western-blot analysis of CEM cells incubated 
in vitro with biotin-labeled anti-histone H1 IgGs for 2 and 24 h. 
H and L — position of heavy and light chains of IgGs
Earlier, we have found that IgGs isolated from blood 
serum of the multiple myeloma and SLE patients and 
purified by the affinity chromatography on the histone 
H1-Sepharose column are capable of stimulating 
proliferation in vitro of human T-leukemia Jurkat 
cells [9, 10]. Here, we addressed more detailed chara-
cterization of these Abs and the analysis of potential 
mechanisms responsible for their proliferative action. 
Besides, we have applied an additional purification 
step — size exclusion HPLC on the Bio-Sil SEC 250 co-
lumn at very low pH 2.6 that excluded a possibility 
of the activity of most potential impurities in the IgG 
preparation [12].
The appearance of the anti-histone H1 IgGs 
in blood serum can be related to a phenomenon 
of the molecular mimicry of some self and foreign an-
tigens [12]. An existence of the polyclonal and mono-
clonal Abs possessing cross-reactivity with histone 
H1 and other intracellular proteins and even with the 
carbohydrate antigens [15–17] might serve as a confir-
mation for such suggestion. However, the mechanisms 
responsible for the ability of the anti-histone H1 IgGs 
to stimulate cell proliferation are poorly understood 
yet. As a working hypothesis, one can suggest that 
these Abs possess cross-reactivity to cellular antigens 
that directly or indirectly activate growth factor recep-
tors present on tumor cells via binding with specific 
cell surface antigens [18, 19]. We have demonstrated 
a cross-reactivity of the anti-histone H1 IgGs with dif-
ferent proteins (potential natural antigens) of CEM 
cells. Earlier, we have used similar procedure (affinity 
chromatography on the columns with Protein A and 
with Histone H1-Sepharose) and showed that secre-
tory IgAs purified from the colostrum of healthy mo-
thers were capable of stimulating proliferation in vitro 
of leukemia cells [11].
Another mechanism, which might be important 
for expression of the proliferation-stimulating activity 
of the anti-histone H1 IgGs could be linked with the 
internalization of these Abs by the treated CEM cells. 
It was found that the Abs possessing antigenic speci-
ficity towards nuclear antigens could penetrate into the 
target cells [20–22]. Since linker histone H1 is present 
in cell nucleus where it participates in chromatin rear-
rangement [23], one can speculate that stimulation 
of proliferation of T-leukemia CEM cells is related to in-
ternalization of the anti-histone IgGs by the targeted 
tumor cells and further translocation of these Abs into 
the cell nucleus.
To answer a question why the anti-histone IgGs 
can stimulate proliferation of CEM cells, we car-
ried out a search in functional domains of the IgG 
molecules regarding a presence of domains that 
might be directly or indirectly involved in the induc-
tion of cell proliferation. As a result of such search, 
we found that the hinge region located in central part 
of the heavy chains of IgG and IgA idiotypes is rich 
in proline residues [24]. It is known that proline-rich 
motives of different cellular proteins are involved in the 
formation of a signaling network in the eukaryotic 
cells through their interaction with the SH3-domains 
of other proteins [25, 26]. Thus, we hypothesized that 
the proline-rich motive of the IgGs might interact with 
specific functional domains of the intracellular proteins 
involved in growth-promoting signaling. To check this 
possibility, we tried to determine possible functional 
motives in primary sequences [27] of the hinge regions 
of human IgGs. Scansite database and Motif Scan pro-
gram (scansite.mit.edu) were used to reach that goal. 
The results of our analysis are presented in the Table. 
It was found that hinge region of IgG 1 and IgG 3 mo-
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lecules contains the motives capable of interacting 
with the Mode 1 binding site of the 14–3–3 protein and 
Src-kinase homology 3 (SH3)-domain of the tyrosine-
protein kinase ITK/TSK known as an interleukin-2- 
inducible T-cell kinase or shortly ITK. 14–3–3 proteins 
belong to a family of conserved regulatory molecules 
expressed in all eukaryotic cells, and they are capable 
of binding numerous functionally diverse signaling 
proteins, including kinases, phosphatases, and trans-
membrane receptors [28]. The tyrosine-protein kinase 
ITK/TSK (EC = 2.7.10.2) plays an essential role in the 
regulation of the adaptive immune response. The anti-
gen presenting cells activate T-cell receptor that allows 
a recruitment of the ITK to the cell membrane, followed 
by a series of phosphorylation of cellular signaling 
proteins, finally leading to lymphokine production, cell 
proliferation, and differentiation [29, 30]. It was found 
that the anti-histone H1 Abs modulated the tolerogenic 
status of the dendritic cells and decreased cytotoxi-
city of the lymphokine-activated killer cells and human 
natural killer cells [31]. Thus, the anti-histone H1 Abs 
can decrease cellular immune reactivity in cancer 
patients, and, in that way, these auto-Abs might be in-
volved in tumor development.
Table. Motives within primary sequences of hinge region of differ-
ent IgG subclasses that were predicted by the analysis using resources 
of Scansite.mit.edu 
Subclasses of IgG Hinge sequences Predicted motives
IgG1 EPKSCDKTHTCPPCP 14–3–3 Mode 1 binding site
IgG2 ERKCCVTCPPCP Not found
IgG3 ELKTPLGDTTTCPRCP
EPKSCDTPPPCPRCP
EPKSCDTPPPCPRCP
EPKSCDTPPCPRCP
Not found
Itk SH3
Itk SH3
Itk SH3
IgG4 SPNMVPHAHHAQ Not found
Note: 14–3–3 Mode 1 binding site — binding site of the adapter protein 
14–3–3. Itk SH3 — Src-kinase homology SH3-domain of tyrosine-protein 
kinase ITK/NSK.
Obtained data suggest that the isolated anti-his-
tone H1 IgGs belong to “anti-tumor immunoglobulins” 
described in [32]. The authors predicted an existence 
of certain B-lymphocyte clones producing anti-tumor 
Abs that, under certain conditions, contribute to tumor 
growth. These Abs can be represented in blood serum 
by IgG or IgM subclasses and be involved in stimula-
tion of tumor growth realized via their negative effect 
on T-lymphocytes, decreased activity of cytotoxic 
lymphocytes, and induction of T-cell tolerance.
On the other hand, there are data showing that 
proliferative effect of some Abs is tightly linked with 
their affinity to cellular receptors involved in cell prolife-
ration. For instance, the level of autoantibodies spe-
cific to estrogen receptor alpha correlates with breast 
cancer cell proliferation [33], and the autoantibodies 
against cell-surface GRP78 promote tumor growth 
in a murine model of melanoma [34].
CONCLUSION
The anti-histone H1 IgGs isolated from blood serum 
of the SLE patients were additionally purified using 
HPLC conducted under strongly acidic conditions 
excluding activity of potential protein impurities. The 
ability of these IgGs to stimulate proliferation of hu-
man T-leukemia CEM cells was demonstrated. Such 
activity is in agreement with a revealed antigenic poly-
specificity of these IgGs towards cellular antigens, 
as well as with their internalization by the treated cells.
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